United States and global research expert with over 10 years of experience covering health-related topics at Statista. His primary focus is on pharma-biotech and the digitization of health. During the coronavirus pandemic, he was responsible for the global coverage of the pandemic at Statista.com.
Research expert
Matej Mikulic
Research expert covering health, pharma & medtech
Latest publishings
Health, Pharma & Medtech U.S. high quality marijuana prices per ounce in 2022 by state
Pharmaceutical Products & Market Leading pharmaceutical & biotech companies in selected EU countries 2024
Pharmaceutical Products & Market Top pharmaceutical and biotech companies by profit growth in 2023
Pharmaceutical Products & Market Top pharmaceutical companies by capex growth in 2023
Pharmaceutical Products & Market Top 50 global pharmaceutical and biotech companies by R&D intensity in 2023
- Pharmaceutical Products & MarketGlobal pharmaceutical industry - statistics & facts
- Health, Pharma & MedtechTop pharmaceutical drugs - Statistics & Facts
- Health, Pharma & MedtechGenerics and biosimilars - Statistics & Facts
- Health, Pharma & MedtechU.S. pharmaceutical industry - statistics & facts
- Health, Pharma & MedtechAnti-aging - Statistics & Facts
statistics
- Average price per ounce of high quality marijuana as of October 2022, by select U.S. state (in U.S. dollars)
- Number of leading pharmaceutical and biotechnological companies in EU countries as of 2024
- World's top 50 pharmaceutical and biotechnology companies based on profit growth in 2023
- World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2023
- World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2023
Topics
About
Matej Mikulic
Research expert covering health, pharma & medtech
Our research department
Gain an in-depth understanding of our research methods and our guiding principles and learn more about our research department.
Customer support
Contact us anytime. We will respond to your inquiry as quickly as possible. Get in touch with us now.